A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZKLJ02 Injection in Healthy Chinese Research Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A randomized, double‐blind, placebo‐controlled, dose‐escalation Phase I clinical study toevaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of singleintravenous administration of ZKLJ02 injection in healthy Chinese research participants
Epistemonikos ID: 04983b19368630a24b4c6371f7381cb0f67f8c0b
First added on: Jun 11, 2026